MEDICINE CARTEL IS FINED 283.5 MILLION RUB

28-11-2019 | 09:19

“Firma Evroservice” CJSC and “Mega Pharma” Ltd. will pay 234 million and 49.5 million RUB accordingly

Earlier FAS found that “Firma Evroservice” CJSC and “Mega Pharma” Ltd. breached Clause 2 Part 1 Article 11 of the Federal e-auction for supplying medicinal drugs and medical products in public healthcare facilities.

Income of cartel participants reached over 800 million RUB. Appeal Court supported the decision made by the antimonopoly body.

“Firma Evroservice” CJSC is on the Register of legal entities held administratively liable under Article 19.28 of the Code on Administrative Violations (unlawful remuneration on behalf of a legal entity), kept by the General-prosecutor’s Office of the Russian Federation.

According to the Register, in 2018 “Firma Evroservice” CJSC was held administratively liable twice for bribing medical officers or healthcare facilities, was fined 1 million RUB and cannot participate in auctions for two years are being included in the Register.

“Targeted anticompetitive conduct can be seen not only in their participation in the cartel but also in bribing staff of medical facilities. To prevent such illegal activities and possible recurrences, the antimonopoly body imposes notable fines upon violators and transfer materials to the law enforcement bodies in order to open a criminal case against unfair business”, commented Head of FAS Anti-Cartel Department Andrey Tenishev.



Site Map

News & Events Press Releases Media Releases Image Library About the FAS Russia What We Do General Information Mission, Goals, Values Priority Setting Institutional Memory Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings GCR Using our website International Cooperation Treaties & Agreements International Working Groups Working Group on Research of Competition Issues in the Market of International Telecommunications (Roaming) Meetings Working Group for Studying Competition Problems in the Pharmaceutical Sector Concept Note Meetings OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 FAS Annual Reports OECD-GVH RCC RCC Newsletter ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 13th session IGE UNCTAD Resolution Russian contributions 14th session IGE UNCTAD Resolution Russian contributions 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD EEU Model Law on Competition ICN BRICS WG (Markets of Social Importance) EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Archive Working Group on Investigating Issues on Pricing in the Oil and Oil Product Markets and Methods of their Functioning Meetings Document Library Legislation Reports & Analytics Cases & decisions Contacts Give feedback Contact us Links Authorities Worldwide